4 Conclusion
In summary, for postoperative breast cancer patients requiring
chemotherapy, a careful risk evaluation for bone marrow suppression
should be conducted before initiating chemotherapy. For patients
undergoing chemotherapy regimens with a moderate-to-high risk of FN,
regardless of the treatment goal (cure, survival extension, or
improvement of disease-related symptoms), the prophylactic use of G-CSF
should be considered. Regular blood examinations should also be
performed during chemotherapy and if bone marrow suppression is
detected, timely corrective treatment is necessary. For febrile
patients, a comprehensive abdominal CT or ultrasound examination should
be conducted after chemotherapy to rule out the possibility of bacterial
pyogenic liver abscess. KPPLA-induced EE is a clinically atypical
infectious disease characterised by rapid progression and a poor
prognosis. In patients with a confirmed KPPLA diagnosis, timely systemic
anti-infective treatment should be administered. If necessary, pyogenic
liver abscess puncture and drainage should also be performed.
Additionally, routine fundus examination should be conducted regularly
[19,27]. Early diagnosis and treatment are essential to preserve
vision, improve prognosis, and prevent serious adverse consequences such
as blindness or enucleation due to EE.